Literature DB >> 18046029

Patent foramen ovale and cryptogenic stroke in older patients.

Michael Handke1, Andreas Harloff, Manfred Olschewski, Andreas Hetzel, Annette Geibel.   

Abstract

BACKGROUND: Studies to date have shown an association between the presence of patent foramen ovale and cryptogenic stroke in patients younger than 55 years of age. This association has not been established in patients 55 years of age or older.
METHODS: We prospectively examined 503 consecutive patients who had had a stroke, and we compared the 227 patients with cryptogenic stroke and the 276 control patients with stroke of known cause. We examined the prevalences of patent foramen ovale and of patent foramen ovale with concomitant atrial septal aneurysm in all patients, using transesophageal echocardiography. We also compared data for the 131 younger patients (< 55 years of age) and those for the 372 older patients (> or = 55 years of age).
RESULTS: The prevalence of patent foramen ovale was significantly greater among patients with cryptogenic stroke than among those with stroke of known cause, for both younger patients (43.9% vs. 14.3%; odds ratio, 4.70; 95% confidence interval [CI], 1.89 to 11.68; P<0.001) and older patients (28.3% vs. 11.9%; odds ratio, 2.92; 95% CI, 1.70 to 5.01; P<0.001). Even stronger was the association between the presence of patent foramen ovale with concomitant atrial septal aneurysm and cryptogenic stroke, as compared with stroke of known cause, among both younger patients (13.4% vs. 2.0%; odds ratio, 7.36; 95% CI, 1.01 to 326.60; P=0.049) and older patients (15.2% vs. 4.4%; odds ratio, 3.88; 95% CI, 1.78 to 8.46; P<0.001). Multivariate analysis adjusted for age, plaque thickness, and presence or absence of coronary artery disease and hypertension showed that the presence of patent foramen ovale was independently associated with cryptogenic stroke in both the younger group (odds ratio, 3.70; 95% CI, 1.42 to 9.65; P=0.008) and the older group (odds ratio, 3.00; 95% CI, 1.73 to 5.23; P<0.001).
CONCLUSIONS: There is an association between the presence of patent foramen ovale and cryptogenic stroke in both older patients and younger patients. These data suggest that paradoxical embolism is a cause of stroke in both age groups. 2007 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2007        PMID: 18046029     DOI: 10.1056/NEJMoa071422

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  128 in total

Review 1.  Prevention of cardioembolic stroke.

Authors:  William David Freeman; Maria I Aguilar
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

2.  Successful use of Alteplase during cardiopulmonary resuscitation following massive PE in a patient presenting with ischaemic stroke and haemorrhagic transformation.

Authors:  Robert Middleton; Juliane Neumann; Simon Michael Ward
Journal:  BMJ Case Rep       Date:  2014-10-31

3.  Prevalence and characteristics of right-to-left shunt in migraine with aura: a survey on 120 Italian patients.

Authors:  L Caputi; Domenico D'Amico; S Usai; L Grazzi; E A Parati; G Bussone
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

4.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack : part 2].

Authors:  P D Schellinger; P Ringleb; W Hacke
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

5.  Interatrial thrombus-in-transit resulting in paradoxical thromboembolism.

Authors:  Sargis Khoobiar; Aaron Vanhise; Renato Apolito; Marc Cohen
Journal:  J Thromb Thrombolysis       Date:  2009-03-18       Impact factor: 2.300

6.  Bilateral macular hole in a patient with chronic renal failure after recurrent deep vein thrombosis.

Authors:  Zisis Gatzioufas; Matthias Krause; Ursula Löw; Berthold Seitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-15       Impact factor: 3.117

7.  An autopsy case of acute cor pulmonale and paradoxical systemic embolism due to tumour cell microemboli in a patient with breast cancer.

Authors:  Sayuri Uga; Shuntaro Ikeda; Sho-ichi Matsukage; Mareomi Hamada
Journal:  BMJ Case Rep       Date:  2012-09-30

8.  Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

Authors:  Scott E Kasner; Balakumar Swaminathan; Pablo Lavados; Mukul Sharma; Keith Muir; Roland Veltkamp; Sebastian F Ameriso; Matthias Endres; Helmi Lutsep; Steven R Messé; J David Spence; Krassen Nedeltechev; Kanjana Perera; Gustavo Santo; Veronica Olavarria; Arne Lindgren; Shrikant Bangdiwala; Ashkan Shoamanesh; Scott D Berkowitz; Hardi Mundl; Stuart J Connolly; Robert G Hart
Journal:  Lancet Neurol       Date:  2018-09-28       Impact factor: 44.182

9.  Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?

Authors:  Alawi A Alsheikh-Ali; David E Thaler; David M Kent
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

Review 10.  Rethinking trial strategies for stroke and patent foramen ovale.

Authors:  David E Thaler; David M Kent
Journal:  Curr Opin Neurol       Date:  2010-02       Impact factor: 5.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.